Genovis Has Signed Distribution Agreement with ADVANSYS Technologies for Life Ltd.

Genovis Has Signed Distribution Agreement with ADVANSYS Technologies for
Life Ltd.

Genovis, a producer of new technologies used for Imaging and Antibody
Engineering, today announced that it has entered into an agreement with
ADVANSYS Technologies for Life Ltd. to exclusive distribute its products
on the Israeli market.

Genovis provides novel technical solutions for Imaging and Antibody
Engineering. The objectives are to maintain a strong, collaborative and
innovative product portfolio for customers in the pharmaceutical
industry and in the academic research community.

Sarah Fredriksson, Chief Executive Officer of Genovis, said “We are
excited to have the opportunity to bring ADVANSYS into our distribution
network and it will allow us to reach a large number of customers in
Israeli and we are looking forward to working with the experienced team
in Advansys”

ADVANSYS is a young and dynamic Company, established by professionals
with long term experience in the promotion of advanced technologies to
researchers and other professionals in the Life Sciences, Biotechnology
and Biomedical industry. The primary goal of ADVANSYS is to supply the
Israeli life science and biomedical market with the latest innovations
in gene, protein and cell analysis. ADVANSYS is committed to provide
continuous support to customers in all stages of application
development, excellent technical support and after-sales service.

"ADVANSYS is striving to present state-of-the-art technologies and high
quality products to its customers.  We are excited to enter a
collaboration with such an innovative company as Genovis AB and look
forward to start promoting its unique product offering in the highly
advanced and promising life sciences market in Israel." said Dr. Eleni
Bantinaki, Director and Founder of ADVANSYS Technologies of Life Ltd.

Find out more, contact: Sarah Fredriksson, CEO, Genovis AB Tel: +46 46
10 12 35 sarah.fredriksson@genovis.com